Ownership history in Blackstone Inc. · 5 quarters on record
This page tracks every 13F SEC filing in which Blackstone Inc. reported a position in BICARA THERAPEUTICS INC (BCAX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 1,224,336 | — | 0% | 0.08% | $19.3M | $15.79 |
| 2025 Q2 | ADDED | 1,224,336 | +196,042 | +19.1% | 0.05% | $11.4M | $9.29 |
| 2025 Q1 | ADDED | 1,028,294 | +115,234 | +12.6% | 0.06% | $13.4M | $13.03 |
| 2024 Q4 | ADDED | 913,060 | +263,060 | +40.5% | 0.07% | $15.9M | $17.42 |
As of 2025 Q4 — sorted by position size